Summary. Metabolic glucose control was followed in 36 patients at 12-month intervals for up to 5 years after a successful combined kidney and segmental duct-occluded pancreas transplantation. All recipients had normal blood glucose levels at each examination. HbA1 values, intravenous glucose tolerance test, C-peptide levels and C-peptide responses to glucagon stimulation were also, on average, within the normal range. Several individual patients had, however, abnormal values for these parameters. At most 46% had abnormal values for HbA1 and intravenous glucose tolerance test, up to 13% showed low C-peptide values and up to 46% of the stimulated C-peptide responses were inadequate at the different intervals. These parameters did not deteriorate with time. This was true both for the whole group of patients as well as for the 6 patients with a 5-year observation time evaluated separately. Despite these abnormalities in glucose metabolism, all patients remained normoglycaemic without need for exogenous insulin up to 5 years after transplantation. The long-term ability of duct-occluded segmental pancreatic grafts to preserve euglycaemia therefore seems to remain intact at least for 5 years.
Introduction
A successful pancreas transplantation implies independency of insulin injections for the diabetic patient. This undoubtedly improves the diabetic recipient's quality of life (Nakache et al. 1989) . A drawback is that insulinindependency is substituted for by potentially lifelong immunosuppressive therapy. However, in combined renal and pancreas transplantation the renal grafting per se necessitates immunosuppressive therapy. Our policy has therefore been to offer uraemic diabetic patients a combined pancreas and kidney transplantation provided no living donor is available.
The primary aim of a successful pancreas transplantation is to normalize the glucose metabolism and to reverse or halt the secondary complications of diabetes. Although normoglycaemia is obtained in diabetic patients after a successfully transplanted pancreas, not all insulin-independent recipients obtain a complete normalization of glucose metabolism (Groth 1988; Landgraf 1989; Holdaas 1990; Nord6n 1990) .
At our centre the segmental duct-occlusion technique with neoprene has been the preferred technique from 1983 to 1988. The purpose of this study was to evaluate the long-term effect on glucose metabolism of combined renal and pancreas transplantation in diabetic recipients with a functioning pancreas graft up to 5 years after transplantation.
Subjects and methods
Patients. From June 1983 to February 1987 uraemic diabetic patients received combined kidney and pancreatic grafts. Twenty-two patients were available for evaluation at 1 year, 16 at 2 years, 13 at 3 years, 10 at 4 years and 6 at 5 years. Successful pancreas transplantation was defined as independency of insulin therapy, consequently patients with partially functioning pancreatic grafts were excluded.
Surgery. The surgical procedure has previously been described (Dubemard et al 1978) . The data are expressed as raeans+SEM cyclosporine A and prednisolone in the first 10 patients; in the remaining patients azathioprine was added. Rejection episodes were treated with i.v. boluses of raethylprednisolone and/or polyclonal antilymphoeyte globuim.
Metabolic evaluation was assessed by the following parameters: Fasting blood glucose; blood glucose was measured by the hexokinase method. Intravenous glucose tolerance test (1VGT); IVGT (25g of glucose) was assessed by the diminuation rate of blood glucose expressed as a Kvalue (Lundbaek 1962) . Glycosylated haemoglobin A1 (HbA1); HbA1 was measured by a microoolumn technique (Bio--Rad, Munich, FRG). Normal range is 6-8%. Basal and stimulated C-peptide; C-peptide was determined by a commercial radioimmunoassay method (Novo Cpeptide kit, Bagsvaerd, Denmark). Stimulation test for C-peptide response was performed by giving 1 mg of glucagon intravenously (Saxlund et al 1987) .
Results
All patients with a functioning graft were examined every 12 months after transplantation. The patient characteristics, medication and renal function 1, 2, 3, 4 and 5 years after transplantation are shown in Table 1 . The patients had suffered from diabetes mellitus for about 30 years before transplantation. The serum creatinine levels were stable during the whole observation period and were within the same range as for diabetic patient with a kidney transplant only.
The data assessing glucose metabolism are summarized in Table 2 . The percentage of patients within the normal range for the various parameters are also shown in the table.
None of the mean values of the metabolic parameters for the overall material showed any tendency to decline with time. Fasting blood glucose levels were normal in all patients at all intervals. The mean HbA1 values were normal or at the upper range of normal. However, the percentage of individual patients within normal range for HbA1 varied. Although the mean K-values were consistently stable for all examinations throughout the study, individual analysis revealed that several patients had abnormal K-values at one or several of the yearly examinations. The normal range for C-peptide at our laboratory is 0.3-1.0 nmol/l. Basal C-peptide levels are at, or slightly above, normal values. The normal response range for stimulated Cpeptide in response to glucagon is above 0.4 nmol/1. A large proportion of the patients exhibited subnormal values.
Discussion
H. Holdaas et al.: Metabolic control after pancreas and kidney transplants metabolic glucose control with time if the fibrosis also replaced islet cells. However, our study demonstrates that duct-occluded pancreatic grafts preserve their capacity to regulate glucose metabolism unchanged at near normal levels up to 5 years following transplantation. This finding is consistent whether the overall material is evaluated as in Table 2 , or if the six patients with functioning grafts for 5 years are analysed separately. Our study indicates that preservation of the exocrine pancreatic tissue is not a prerequisite for the long-term endocrine function of pancreatic transplants.
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